APA (7th ed.) Citation

R, G., A, A., & R, A. (2025). Optimizing neoadjuvant radiotherapy for locally advanced esophageal squamous cell carcinoma: A comprehensive review on the role of concomitant or sequential immune checkpoint inhibitors. Esophagus : official journal of the Japan Esophageal Society, 22(1), 5. https://doi.org/10.1007/s10388-024-01097-1

Chicago Style (17th ed.) Citation

R, Ghalehtaki, Amini A, and Abyaneh R. "Optimizing Neoadjuvant Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Comprehensive Review on the Role of Concomitant or Sequential Immune Checkpoint Inhibitors." Esophagus : Official Journal of the Japan Esophageal Society 22, no. 1 (2025): 5. https://doi.org/10.1007/s10388-024-01097-1.

MLA (9th ed.) Citation

R, Ghalehtaki, et al. "Optimizing Neoadjuvant Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Comprehensive Review on the Role of Concomitant or Sequential Immune Checkpoint Inhibitors." Esophagus : Official Journal of the Japan Esophageal Society, vol. 22, no. 1, 2025, p. 5, https://doi.org/10.1007/s10388-024-01097-1.